NV
NKTR icon

Nair Vinay’s Nektar Therapeutics NKTR Stock Holding History

Nair Vinay’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$322K Buy
+1,716
New +$295K 0.4% 106

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Nair Vinay's NKTR Position: Q2 2015 in Review

Nair Vinay opened a new position in Nektar Therapeutics (NKTR) in Q2 2015: 1,716 shares worth $322K. The stake represents 0.4% of the portfolio and ranks #106 among its holdings.

181 funds tracked by Wall St. Rank hold NKTR as of Q2 2015.

  • Nair Vinay held 1,716 shares of Nektar Therapeutics worth $322K as of Q2 2015.
  • Nektar Therapeutics was a new Nair Vinay position in Q2 2015.
  • Nektar Therapeutics made up 0.4% of Nair Vinay's portfolio in Q2 2015, its #106 holding.
  • 181 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2015.

Based on Nair Vinay's 13F filing for Q2 2015, filed 12 Aug 2015.